Alfuzosin + Tadalafil Tablet Franchise in Ahmedabad

Urology Care Tablet Supplier in Mumbai

BPH & ED Medicine Distributor in Delhi

Urological Pharma Franchise in Bangalore

Alfuzosin Tadalafil Tablet Stockist in Hyderabad
Urology Care Tablet Manufacturer & Exporter in Chandigarh

Home/Products /alfuzosin-10mg-tadalafil-2-5mg-tablet

Alfuxyle T 2.5 Tablet

Composition : Alfuzosin (10mg) + Tadalafil (2.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹0/-

Alfuxyle T 2.5 Tablet contains Alfuzosin 10mg + Tadalafil 2.5mg, a dual-action therapy for effective management of BPH and erectile dysfunction. Alfuzosin relaxes prostate and bladder muscles to improve urinary flow, while Tadalafil enhances blood circulation to support erectile function.

This combination is clinically preferred by urologists due to its synergistic action, safety profile, and patient tolerability, providing reliable symptom relief for both urinary and sexual health issues. Patients experience better quality of life, improved urinary comfort, and enhanced sexual performance.

For franchise partners, Alfuxyle T 2.5 Tablet is a high-demand product in the urology care segment, ensuring strong market acceptance and repeat prescriptions. Its dual-therapy approach makes it a profitable addition to specialty portfolios, boosting sales and strengthening business growth.

With increasing prevalence of BPH and erectile dysfunction, Alfuxyle T 2.5 Tablet offers sustainable sales opportunities, helping partners establish a strong presence in the urology care segment.

Read More

About the Product

Alfuxyle T 2.5 Tablet contains Alfuzosin 10mg + Tadalafil 2.5mg, a dual-action therapy for effective management of BPH and erectile dysfunction. Alfuzosin relaxes prostate and bladder muscles to improve urinary flow, while Tadalafil enhances blood circulation to support erectile function.

This combination is clinically preferred by urologists due to its synergistic action, safety profile, and patient tolerability, providing reliable symptom relief for both urinary and sexual health issues. Patients experience better quality of life, improved urinary comfort, and enhanced sexual performance.

For franchise partners, Alfuxyle T 2.5 Tablet is a high-demand product in the urology care segment, ensuring strong market acceptance and repeat prescriptions. Its dual-therapy approach makes it a profitable addition to specialty portfolios, boosting sales and strengthening business growth.

With increasing prevalence of BPH and erectile dysfunction, Alfuxyle T 2.5 Tablet offers sustainable sales opportunities, helping partners establish a strong presence in the urology care segment.

Common side effects may include dizziness, headache, flushing, nasal congestion, or mild gastrointestinal discomfort. Rarely, patients may experience low blood pressure, fainting, or priapism. Any severe or persistent adverse effects should be reported to a healthcare professional immediately.

Alfuxyle T 2.5 Tablet is indicated for the treatment of benign prostatic hyperplasia (BPH) with associated lower urinary tract symptoms, and in patients experiencing erectile dysfunction. It helps improve urinary flow, reduce urinary frequency and urgency, and enhance erectile function.

Alfuxyle T 2.5 Tablet should be taken exactly as prescribed. Patients with severe liver or kidney impairment, low blood pressure, heart disease, or a history of stroke should use this medication cautiously. Do not combine with nitrates or other PDE-5 inhibitors, as this may cause serious cardiovascular effects.

Store Alfuxyle T 2.5 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date mentioned on the pack.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation